FluMist Quadrivalent (MedImmune, LLC)


Welcome to the PulseAid listing for the FluMist Quadrivalent drug offered from MedImmune, LLC. This pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: MedImmune, LLC
NON-PROPRIETARY NAME: Influenza Vaccine Live Intranasal
SUBSTANCE NAME: INFLUENZA A VIRUS A/SLOVENIA/2903/2015 (H1N1) LIVE (ATTENUATED) ANTIGEN; INFLUENZA A VIRUS A/NEW CALEDONIA/71/2014 (H3N2) LIVE (ATTENUATED) ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 LIVE (ATTENUAT
TYPE: VACCINE
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2017-08-25
END MARKETING DATE: 0000-00-00


FluMist Quadrivalent VACCINE Details:

Item DescriptionFluMist Quadrivalent from MedImmune, LLC
LABELER NAME: MedImmune, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10000000; 10000000; 10000000; 10000000([FFU]/.2mL; [FFU]/.2mL; [FFU]/.2mL; [FFU]/.2mL)
START MARKETING DATE: 2017-08-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66019-304_1b901d34-b979-4a9f-9200-297c290e8406
PRODUCT NDC: 66019-304
APPLICATION NUMBER: BLA125020

Other INFLUENZA A VIRUS A/SLOVENIA/2903/2015 (H1N1) LIVE (ATTENUATED) ANTIGEN; INFLUENZA A VIRUS A/NEW CALEDONIA/71/2014 (H3N2) LIVE (ATTENUATED) ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 LIVE (ATTENUAT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
MedImmune, LLCFluMist Quadrivalent